Buy Cefpodoxime
Cefpodoxime

1.93
Cefpodoxime (cefpodoxime proxetil) is an oral cephalosporin antibiotic used to treat infections caused by susceptible bacteria. Common applications include ear infections, throat infections, and community-acquired pneumonia. It works by preventing bacterial growth, allowing the body to overcome the infection while reducing associated inflammatory symptoms and discomfort.


Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Cefpodoxime Proxetil
Reference Brand
Orelox
Manufacturer
Sanofi
Product Form
Tablet, Oral suspension
Regulatory Classification
Rx
Primary Category
Antibiotics
Product Category
Anti-infectives for systemic use, Antibacterials, Third-generation cephalosporins
Pharmacological Class
Cephalosporins
Manufacturer Description
A prescription antibiotic used to treat various bacterial infections of the respiratory tract, skin, and urinary system.
Mechanism of Action
Cefpodoxime is a cephalosporin antibiotic that works by interfering with the formation of the bacterial cell wall. By preventing bacteria from building a stable protective wall, it causes the bacteria to rupture and die, thereby clearing the infection from the body.
Route of Administration
Oral
Onset Time
1-3 hours
Duration
12 hours
Contraindications
Cephalosporin allergy, Penicillin hypersensitivity, History of severe allergic reactions to beta-lactams
Severe Adverse Events
Severe skin rash, Persistent vomiting, Watery or bloody diarrhoea, Yellowing of skin or eyes, Difficulty breathing
Common Side Effects
Nausea, Stomach ache, Fatigue
Uncommon Side Effects
Diarrhoea, Bloating, Dizziness, Headache
Drug Interactions
Antacids, Ranitidine, Famotidine, Probenecid, Warfarin
Pregnancy Safety Warnings
Use only if clearly needed and prescribed by a doctor.
Age Restrictions
Suitable for children and adults (dosage varies by weight).
Storage Guidelines
Store at room temperature away from moisture; prepared liquid should be kept in a fridge.
Related Products
Cefixime, Amoxicillin, Co-amoxiclav

Cefpodoxime FAQ

Can I take cefpodoxime with antacids?

Cefpodoxime absorption is not markedly affected by antacids, so they can be taken together. However, spacing them by at least two hours may minimize any potential reduction in gastric acidity that could theoretically alter drug dissolution.

What should I do if I develop a rash while on cefpodoxime?

A mild rash may resolve without intervention, but any new skin eruption should be reported promptly. If the rash spreads, is accompanied by fever, or shows blistering, seek urgent medical care as it could signify a serious allergic reaction.

Is cefpodoxime safe for use during pregnancy?

Cefpodoxime is classified as category B in the UK, indicating that animal studies have not shown fetal risk and there are limited human data. It should be prescribed only when clearly needed, after weighing potential benefits against any theoretical risks.

How does cefpodoxime compare to amoxicillin?

Both are β-lactam antibiotics, but cefpodoxime (a third-generation cephalosporin) has broader activity against Gram-negative organisms and is more resistant to many β-lactamases. Amoxicillin is generally preferred for common community infections unless resistance or allergy is a concern.

Can I travel internationally with cefpodoxime tablets?

Yes, but you should carry a copy of the prescription and a letter from your prescriber explaining the medical need. Some countries require documentation for imported prescription medicines.

Do I need to avoid dairy products while taking cefpodoxime?

Dairy does not interfere with cefpodoxime absorption, so you may continue normal consumption of milk, cheese, and yoghurt.

What is the typical duration of therapy for sinusitis?

For uncomplicated acute bacterial sinusitis, cefpodoxime is usually prescribed for 5-7 days. Longer courses are reserved for more severe or refractory infections.

Is there a risk of developing antibiotic resistance with cefpodoxime?

All antibiotics carry a risk of fostering resistant bacteria if used improperly. Completing the full course, avoiding unnecessary use, and following prescribing guidelines help mitigate this risk.

Can I crush a cefpodoxime tablet for a feeding tube?

Cefpodoxime tablets are not formulated for crushing. If an alternative route is required, consult a pharmacist for a suitable liquid formulation or a different antibiotic.

How should I dispose of unused cefpodoxime tablets?

Do not flush tablets down the toilet. Return them to a local pharmacy’s medicine take-back program or follow the NHS guidelines for safe disposal of medicines.

Cefpodoxime Proxetil: Antibiotic Overview

Cefpodoxime Proxetil is an oral third-generation cephalosporin antibiotic. It is supplied as 100 mg and 200 mg pill tablets and is prescription-only in the United Kingdom, regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The medication works by disrupting bacterial cell-wall synthesis, making it effective against a range of Gram-positive and Gram-negative organisms that cause common infections such as sinusitis, otitis media, bronchitis, and uncomplicated urinary tract infections.

How Cefpodoxime Works in the Body

Cefpodoxime belongs to the β-lactam class of antibiotics. After oral ingestion, the prodrug (Cefpodoxime Proxetil) is rapidly hydrolyzed in the gastrointestinal tract to the active cefpodoxime molecule, which reaches peak plasma concentrations within 1-2 hours. The drug binds irreversibly to penicillin-binding proteins (PBPs) that are essential for cross-linking peptidoglycan strands in the bacterial cell wall. Inhibition of PBPs leads to weakened cell walls and, ultimately, bacterial lysis.

Key pharmacokinetic points:

  • Absorption: Approximately 70 % of the oral dose is absorbed; food modestly reduces the rate but not the extent of absorption.
  • Distribution: Widely distributed in extracellular fluid; modest penetration into the cerebrospinal fluid unless the meninges are inflamed.
  • Metabolism & Excretion: Primarily eliminated unchanged by the kidneys; renal clearance correlates with glomerular filtration rate.
  • Half-life: 2-3 hours in individuals with normal renal function, supporting twice-daily dosing.

Conditions Treated by Cefpodoxime

Cefpodoxime is approved by the MHRA for the treatment of the following infections (as listed in the UK Summary of Product Characteristics):

  • Upper respiratory tract infections: Acute bacterial sinusitis, acute otitis media, community-acquired pneumonia (mild-to-moderate).
  • Lower respiratory tract infections: Acute exacerbations of chronic bronchitis.
  • Skin and soft-tissue infections: Uncomplicated cellulitis, impetigo.
  • Urinary tract infections: Uncomplicated cystitis caused by susceptible organisms.

These indications reflect the drug’s activity against common pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and many Gram-negative Enterobacteriaceae.

Off-Label and Investigational Applications

Evidence from peer-reviewed studies suggests potential benefit of cefpodoxime in certain off-label scenarios, for example:

  • Sexually transmitted infections: Limited data indicate activity against Chlamydia trachomatis, though recommended regimens prefer doxycycline.
  • Prophylaxis for surgical procedures: Some studies assess cefpodoxime as a single pre-operative dose for clean-contaminated surgeries; however, standard prophylaxis in the UK usually employs cefazolin or amoxicillin-clavulanic acid.

These uses are not approved by the MHRA. Off-label prescribing must be guided by a qualified healthcare professional who evaluates the risk-benefit balance for the individual patient.

Who Should (and Should Not) Use Cefpodoxime?

Ideal candidates are adults with confirmed or strongly suspected bacterial infections that are susceptible to third-generation cephalosporins.

Absolute contraindications

  • Known hypersensitivity to cefpodoxime, any cephalosporin, or penicillin.
  • History of a severe, immediate-type hypersensitivity reaction (e.g., anaphylaxis) to β-lactam antibiotics.

Relative contraindications / cautions

  • Severe renal impairment (creatinine clearance < 30 mL/min); dosage reduction is required.
  • Pregnancy (Category B in the UK): generally considered safe, but use only if clearly needed.
  • Breast-feeding: small amounts are excreted in breast milk; monitoring of the infant is advisable.

Special populations

  • Elderly: Age-related decline in renal function may necessitate dose adjustment.
  • Pediatric: Cefpodoxime is approved for children ≥ 6 months; dosing is weight-based and differs from adult regimens.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Gastrointestinal upset (nausea, diarrhoea, abdominal pain) - reported in > 1 % of recipients.
  • Headache - usually mild and transient.
  • Rash or mild pruritus - often self-limiting.

Serious Adverse Events

  • Severe allergic reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis, anaphylaxis - require immediate medical attention.
  • Clostridioides difficile colitis: Antibiotic-associated diarrhoea can become severe; monitor for persistent watery stools and abdominal cramping.
  • Hematologic abnormalities: Rare neutropenia, thrombocytopenia.

Drug Interactions

  • Probenecid: Reduces renal excretion of cefpodoxime, increasing serum concentrations; dose adjustment may be necessary.
  • Warfarin: Cephalosporins can potentiate anticoagulant effect; periodic INR monitoring is recommended.
  • Oral contraceptives: Limited evidence suggests possible reduction in contraceptive efficacy; a backup method should be considered.

No interaction data are available for many newer biologics; patients should disclose all concurrent medicines, including over-the-counter products and herbal supplements.

Food and Lifestyle Interactions

  • Food: Taking the tablet with or without food is acceptable; high-fat meals may slightly delay absorption but do not affect overall exposure.
  • Alcohol: No direct pharmacologic interaction, but excessive alcohol may exacerbate gastrointestinal side effects.
  • Driving: Cefpodoxime does not impair cognition; however, severe diarrhoea or dizziness could affect ability to operate machinery safely.

Dosing and Administration Guidelines

Standard adult dosing (based on the UK SPC):

  • Mild-to-moderate infections: 100 mg tablet twice daily (every 12 hours).
  • Moderately severe infections: 200 mg tablet twice daily.

Special population adjustments:

  • Renal impairment: Reduce dose by 50 % for creatinine clearance 30-50 mL/min; consider extending dosing interval for clearance < 30 mL/min.
  • Elderly: Assess renal function; dose may need reduction similar to renal impairment guidelines.

Administration tips:

  • Swallow the tablet whole with a full glass of water.
  • Do not crush or chew unless specifically advised by a pharmacist.
  • Complete the full prescribed course, even if symptoms improve, to prevent resistance.

Missed dose:

  • Take the missed dose as soon as remembered unless it is close to the time of the next scheduled dose; do not double the dose.

Overdose:

  • Symptoms may include nausea, vomiting, diarrhoea, and possible renal dysfunction.
  • Seek urgent medical care; activated charcoal may be considered if presentation is early.

Discontinuation:

  • No tapering is required; abrupt cessation is acceptable once the prescribed course is finished.

Monitoring and Follow-Up

  • Renal function: Baseline serum creatinine and periodic monitoring for patients with known kidney disease or those receiving prolonged therapy.
  • Clinical response: Evaluate symptom resolution within 48-72 hours; lack of improvement may warrant culture-directed therapy or alternative antibiotics.
  • Adverse reactions: Prompt assessment of any rash, severe diarrhoea, or signs of hypersensitivity.

Storage and Handling

  • Store tablets at room temperature (15-25 °C), protected from moisture and direct sunlight.
  • Keep the container tightly closed and out of reach of children.
  • Do not use tablets after the expiry date printed on the package; discard according to local pharmacy guidelines.

Medication-Specific Glossary

β-lactamase
An enzyme produced by some bacteria that degrades β-lactam antibiotics, rendering them ineffective.
Cephalosporin
A class of β-lactam antibiotics divided into generations; third-generation agents like cefpodoxime have expanded Gram-negative coverage.
Renal clearance
The volume of plasma cleared of a drug by the kidneys per unit time; essential for dosing adjustments in impaired kidney function.
Therapeutic window
The range of drug concentrations in the blood that yields optimal efficacy with minimal toxicity.

Medical Disclaimer

This article provides educational information about cefpodoxime proxetil and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Cefpodoxime is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Waar kunt u Gezondheid van Vrouwen bestellen - Nolvadex nabehandeling Treatment guide for Type 2 Diabetes Tablets: - Invokana Generic